LOREN NOVAK: Open Payments
NPI 1689601270 · VISTA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,066 in 79 payments from 25 companies in 2025. Trend: 2023 $2,109 · 2024 $1,683 · 2025 $2,066
Food & beverage: $2,064Travel & lodging: $2
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 10 | $264 |
| AstraZeneca Pharmaceuticals LP | 12 | $221 |
| Novo Nordisk Inc | 9 | $198 |
| ABIOMED | 1 | $150 |
| ABBVIE INC. | 6 | $149 |
| GlaxoSmithKline, LLC. | 6 | $118 |
| Boston Scientific Corporation | 2 | $113 |
| CeQur Corporation | 1 | $90 |
| Janssen Pharmaceuticals, Inc | 3 | $80 |
| Lundbeck LLC | 3 | $79 |
Products named: AIRSUPRA, KISUNLA, REXULTI, TRELEGY ELLIPTA, WaveWriter Alpha Prime 16, MOUNJARO, CeQur Simplicity, Wegovy.
Industry payments across CA — which companies pay providers there.
